跳至主要内容
临床试验/ITMCTR2100005280
ITMCTR2100005280招募中未知

Cardiology

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai , China0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 15(—)
性别
All

入选标准

  • The diagnostic criteria for hypertension were formulated according to the guidelines for the Prevention, Detection, Evaluation and Management of Hypertension in Adults in the United States 2017: Hypertensive patients with a 24-h ambulature of 130mmHg= diastolic blood pressure < 160mmHg and/or 90mmHg= diastolic blood pressure < 100mmHg after 3 months of lifestyle intervention with or without antihypertensive drugs. The standard of TCM disease differentiation and syndrome differentiation refers to the standard of liver-yang hyperactivity syndrome in guiding Principles for Clinical Research of New Chinese Medicine and Guiding Principles for Clinical Diagnosis and Treatment of Hypertension. Main symptoms: ? dizziness; (2) a headache; Secondary symptoms: ? irritable; (2) mouth bitter; ? Insomnia,; Lumbar acid (4); ? Pulse string number or inch pulse alone flourishing; ? Pulse string length, straight inch mouth. One of the main disease necessary, and see the second disease two.

排除标准

  • (1) allergic to any ingredient in the study drug;
  • (2) with serious or poorly controlled diseases, such as heart failure, congenital heart disease, rheumatic heart disease, serious arrhythmias or arrhythmias leading to inaccurate blood pressure measurement (such as atrial fibrillation), etc.;
  • (3) patients with new myocardial infarction or recurrent unstable angina pectoris (usually within 12 weeks);
  • (4) Newly diagnosed cerebrovascular diseases within 6 months before inclusion;
  • (5) Patients with previous or existing diagnosed kidney disease, including diabetic nephropathy, impaired renal function, eGFR < 60mL /min/1.73m2;
  • (6) Secondary hypertension: sleep apnea syndrome, pheochromocytoma, renal artery stenosis, primary aldosteronism, cortisolism, large artery disease, drug-induced hypertension, etc.;
  • (7) Patients with severe liver disease (including ALT or AST=2.5 times the upper limit of normal value) or biliary tract occlusion;
  • (8) Patients with total gastrectomy, subtotal gastrectomy and limited oral drug absorption diseases such as short bowel syndrome;
  • (9) Associated diseases such as autoimmune diseases, acute inflammation, tumors, peripheral vascular diseases, lower limb venous thrombosis and other diseases that may affect the results of this study;
  • (10) combination of cognitive and emotional disorders can not effectively cooperate;
  • (11) women who are pregnant or breast-feeding and who plan to become pregnant are unwilling or do not take adequate contraceptive measures;
  • (12) Patients determined by the investigator to be unsuitable for the study

研究者

发起方
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai , China

相似试验